Loading...
Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature
Immune checkpoint inhibitors have emerged as a novel treatment in a wide variety of malignancies; however, it is associated with a distinctive array of side effects known as immune-related adverse events. Hyperprogression is defined as an accelerated growth of disease burden in patients treated with...
Na minha lista:
| Udgivet i: | J Investig Med High Impact Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020406/ https://ncbi.nlm.nih.gov/pubmed/33787380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709621992207 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|